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Abstract 
 
Background: The aim of this study was to investigate the correlation between 
autonomic dysfunction in multiple sclerosis (MS) and brainstem dysfunction 
evaluated with the vestibular evoked myogenic potentials (VEMP) score and 
conventional MRI. 
 
Methods: Forty-five patients with the diagnosis of clinically isolated syndrome 
(CIS) suggestive of MS were enrolled. VEMP, heart rate and blood pressure 
responses to the Valsalva maneuver, heart rate response to deep breathing and 
pain provoked head-up tilt table test, as well as brain and spinal cord MRI were 
performed. 
 
Results: There was no difference in the VEMP score between patients with and 
without signs of sympathetic or parasympathetic dysfunction. However, patients 
with syncope had significantly lower VEMP score compared to patients without 
syncope (p<0,01). Patients with orthostatic hypotension (OH) showed a trend of 
higher VEMP score compared to patients without OH (p=0,06). There was no 
difference in the presence of lesions in the brainstem or cervical spinal cord 
between patients with or without any of the studied autonomic parameters. The 
model consisting of a VEMP score of ≤5 and normal MRI of the midbrain and 
cervical spinal cord has sensitivity and specificity of 83% for the possibility that 
the patient with MS can develop syncope. 
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Conclusions: Pathophysiological mechanisms underlying functional and 
structural disorders of autonomic nervous system in MS differ significantly. 
While preserved brainstem function is needed for development of syncope, 
structural disorders like OH could be associated with brainstem dysfunction. 
 
 
Key words: Syncope, orthostatic hypotension, brainstem, autonomic nervous 
system, multiple sclerosis, clinically isolated syndrome
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Highlights 
 Pathophysiological differences exist between different autonomic 
disorders in MS. 
 Preserved brainstem function is needed for development of syncope in 
MS. 
 Orthostatic hypotension could be associated with brainstem dysfunction 
in MS.  
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1. Introduction 
 
Evidence suggests that brainstem involvement in multiple sclerosis (MS) is 
related to long-term prognosis for patients with clinically isolated syndrome 
(CIS). (1) However conventional MRI shows poor correlation with clinical 
symptoms, especially in the brainstem region. (2) We have recently developed a 
novel way to interpret vestibular evoked myogenic potentials (VEMP) in MS, 
which enables better evaluation of brainstem dysfunction than the MRI, the so-
called VEMP score. (3) The VEMP score is the sum of four 4-graded scores 
derived from the evaluation of 2 ocular VEMPs (oVEMP) and 2 cervical VEMPs 
(cVEMP) (one on each side for each VEMP type), and it correlates well with 
disability and disease duration. oVEMPs evaluate the upper part of the brainstem 
(midbrain and upper pons), while cVEMPs evaluate the lower part of the 
brainstem (lower pons and medulla oblongata), as well as upper parts of the 
cervical spinal cord. This neurophysiological method enables complete 
evaluation of vestibulo-ocular and vestibulo-spinal pathways dysfunction in MS 
patients. 
Several studies have suggested that autonomic dysfunction in MS is a 
consequence of lesions in key regions of the central nervous system, which are a 
part of the reflex arc responsible for normal function of the autonomic nervous 
system; such as nuclei in the periventricular region of the fourth ventricle in the 
brainstem as well as medullar lesions. (4) Studies point to an increased 
frequency of autonomic dysfunction in patients who have lesions in the pons, 
and a correlation has been found between atrophy of the spinal cord and 
orthostatic dysfunction, indicating that axonal degeneration, and not just 
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demyelination, influences the appearance of autonomic dysfunction. (5,6) For a 
better understanding of autonomic dysfunction, autonomic nervous system 
disorders can be classified as structural and functional. (7) Structural disorders 
are defined as having demonstrable pathologic abnormalities that directly affect 
autonomic function, prototype of a structural disorder being orthostatic 
hypotension (OH). On the other hand, functional disorders currently have no 
consistently demonstrable pathologic basis, and are primarily defined by 
symptomology; the prototypes are syncope and postural orthostatic tachycardia 
syndrome (POTS). 
We therefore aimed to investigate the correlation between autonomic 
dysfunction (structural and functional) in MS and brainstem dysfunction 
evaluated with the VEMP score and conventional MRI. 
 
2. Methods 
 
2.1. Design 
 
This was a prospective, cross sectional study which included consecutive 
patients who were diagnosed with CIS from the 1st of August 2014 until 1st of 
March 2015 at the Department of Neurology, University Hospital Center Zagreb - 
a tertiary medical center and a referral center for MS. The diagnosis was made if 
the patient had clinical symptoms and/or signs consistent with demyelinating 
disease of the central nervous system and if brain and/or spinal cord MRI 
showed at least one demyelinating lesion. CSF analysis was performed in all 
patients to exclude MS mimics. 
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Patients were excluded if there was a history of heart disease, however 
cardiological work-up was not performed on the subjects prior to the study. 
Ethical committees of the University Hospital Center Zagreb and University of 
Zagreb, School of Medicine approved the study. All participants gave informed 
consent. 
 
2.2.Cardiovascular autonomic system testing 
 
All tests were performed in a quiet and dimly lit room. Patients were instructed 
not to drink coffee or smoke before the testing. Blood pressure and heart rate 
values were recorded using a Task Force Monitor (TFM) (CNSystems 
Medizintechnik AG, Austria). After the patient was placed supine on a testing 
table, pressure cuff and ECG electrodes were adjusted at appropriate sites. A 
peripheral vein catheter was installed in the antecubital or radial vein of the 
right arm, and 15 minutes of settling period was given before recording.  
The following tests were performed as described previously (8,9): heart rate and 
blood pressure responses to Valsalva maneuver, as a measure of 
parasympathetic and sympathetic function, respectively; heart rate response to 
deep breathing as a measure of parasympathetic function and blood pressure 
response to passive tilt in the duration of 10 minutes, as a measure of 
sympathetic function.  
The Valsalva maneuver was performed in the supine position by blowing for 15 s 
through a mouthpiece connected to a mercury manometer. The height of the 
mercury column was maintained at 40 mm. There was a small air leak in the 
system to prevent closing of the glottis. The test was repeated until a 
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reproducible response was obtained. The Valsalva ratio (VR) was calculated as 
the ratio of the shortest RR interval during or after phase II of the maneuver to 
the longest RR interval in phase IV of the maneuver. The following parameters 
from the blood pressure response to Valsalva maneuver were measured: 
maximal drop of the mean blood pressure during phase II, the peak of the mean 
blood pressure at the end of late phase II (recovery), overshoot in the phase IV, 
maximal pulse pressure drop during phase II and pressure recovery time. 
The deep breathing test was performed in the supine position over 9 respiratory 
cycles; the best six responses were chosen and the respective respiratory sinus 
arrhythmia (RSA) amplitudes were averaged. RSA amplitude was defined as the 
difference between the end of expiration and end of inspiration in heart rate.  
After these tests, a 10-minute pain provoked head-up tilt table test (PPHUT) was 
performed. (10) It consisted of 10 min 70° passive tilt and if after the tilted phase 
there was no positive response, a painful stimulus was applied in the shape of a 
needle prick with 0.7 mm diameter needle on the dorsum of the hand. Responses 
to passive tilt were defined as follows: 
1. Vasovagal Syncope was defined according to the modified Vasovagal 
Syncope International Study (VASIS) classification (11) 
2. OH was defined as a sustained reduction of systolic blood pressure of at 
least 20 mm Hg or diastolic blood pressure of 10 mm Hg within 3 min of 
head-up tilt to 70° on a tilt table. (12) 
3. POTS was defined as an increment of heart rate (HR) ≥30 bpm for adults, 
and ≥40 bpm for patients younger than 19 years on passive tilt and in the 
absence of orthostatic hypotension. (12)  
 9 
All results were interpreted according to the cardiovagal index (parasympathetic 
function) and adrenergic index (sympathetic function) of the Composite 
Autonomic Scoring Scale (CASS). (13) 
 
 
2.3. Vestibular evoked myogenic potentials  
 
Methods of recordings and analysis of recorded data were designed according to 
previously described details. (14,15) 
During the experiment, participants sat in a comfortable chair. Patients were 
instructed to slightly move their head away from the back of the chair and push 
it against the elastic band around the forehead in order to activate the 
sternocleidomastoid muscle. The contraction of muscle was maintained due to 
the cooperation of patients in maintaining the same position during the test. 
Participants were also instructed to direct their gaze to the ceiling in order to 
activate ocular muscles. The evoked response from the sternocleidomastoid 
muscle (SCM) was recorded from the active surface electrode placed on the 
middle of the belly of the SCM of the stimulated side and referred to the surface 
electrode placed on the tendon of the same SCM. The evoked response from the 
ocular muscle (OM) was recorded from two surface electrodes. The active 
electrode was situated 2 cm below the contralateral eye, and referred to the 
reference electrode 1 cm below. The impedance of the electrodes was reduced to 
< 5 kΩ. 
The stimuli were delivered by a pair of headphones in series of 50 trials to one 
ear at a time and repeated two times for each ear in order to provide 
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reproducibility. The presented stimuli were acoustic clicks of 1 ms duration at an 
intensity of 130 dB sound pressure level (SPL) and a stimulation frequency of 1 
Hz. 
Recordings were performed using a Brain Products Brain Vision Recorder (Brain 
Products GmbH Munich, Germany) and the analysis of the recorded data was 
performed using a Brain Products Brain Vision Analyzer (Brain Products GmbH 
Munich, Germany). Signals were filtered with bandpass filter from 0.5 Hz to 1000 
Hz. For the purpose of the analysis, signals were divided in segments of 120 ms 
duration (20 ms before the stimulus appearance and 100 ms after the stimulus 
appearance) and averaged for each set of 50 trials. From the averaged responses 
from the two sets, the grand average was computed and used for further 
analysis. 
The following VEMP components were analyzed: peak-to-peak n10-p13 
amplitude, n10 and p13 latencies for oVEMP, and normalized p13-n23 
amplitude, p13 and n23 latencies for cVEMP. We used baseline normalized 
values of the SCM amplitude data instead of the absolute value of the amplitude, 
because absolute amplitude of the evoked response depends on the amplitude of 
the muscle activity (muscle contraction) and is not a reliable measure. The 
baseline normalized value of amplitude is calculated by dividing the absolute 
peak to peak amplitude (p13-n23) with the mean value of rectified activity of 
muscle in the period prior the stimulus. For the OM amplitudes we used absolute 
values. Due to the variability of evoked potentials, SCM amplitudes were 
considered abnormal if the amplitude was decreased for > 1.0 standard 
deviation compared to the mean value of the laboratory or when it was 
decreased for > 50% compared to the contralateral response. OM amplitudes 
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were considered abnormal if the amplitude was < 50% of the mean value of the 
laboratory or when it was decreased for > 50% compared to the contralateral 
response. Similarly, latencies were considered prolonged when there was an 
increase in > 2.5 standard deviations to the mean value of the laboratory. Absent 
responses (presumed conduction blocks) were also considered as abnormal 
findings.  
All VEMP results were interpreted according to the VEMP score. (3) The VEMP 
score is the sum of four 4-graded scores derived from the evaluation of each 
VEMP. The 4 grades are: 0 = normal, 1 = increased latency with normal 
amplitude and morphology of major potentials, 2 = decrease in amplitude or 
altered morphology of major potentials, 3 = absence of a major potential. 
Minimal and maximal values of the VEMP score are 0 and 12, respectively. 
Examples of normal and pathological VEMP tracings are presented in figures 1 
and 2, respectively. 
 
 
2.3. MRI 
 
All MS patients performed brain MRI on a 1.5T MRI. Cervical spinal cord MRI was 
analyzed if it was available. MRI sequences included multi-planar dual fast spin-echo 
PD and T2-WI, FLAIR and T1 postcontrast sequences. A neurologist with at least 5 
years of experience in MS reviewed all MRIs for the presence of lesions.  
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2.4. Outcomes 
 
Primary outcome was to determine whether autonomic dysfunction in MS 
correlates with the VEMP score. This was assessed by: 1) the correlation of the 
adrenergic and cardiovagal index of the CASS with the VEMP score; 2) the 
correlation of different responses to passive tilt (OH, syncope and POTS) with 
the VEMP score. 
Secondary outcomes were: 1) to determine the correlation of the adrenergic and 
cardiovagal index of the CASS with presence of MRI lesions in the brainstem; 2) 
to determine the correlation of different responses to passive tilt (OH, syncope 
and POTS) with presence of MRI lesions in the brainstem; 3) to develop the 
model that can predict autonomic dysfunction in MS. 
 
 
2.5. Statistical analysis 
Statistical analysis was performed using the IBM SPSS software, version 20. 
Differences in the distribution of qualitative variables were determined with the 
χ2 test, while the differences in quantitative variables were determined with the 
use of non-parametric Mann-Whitney U test. Receiver Operating Characteristics 
(ROC) curves were used in order to interpret sensitivity and specificity of 
proposed methods. P values less than 0.05 were considered as significant. 
 
 
 
 
 13 
3. Results 
 
3.1. Patients 
 
During the study period 45 patients, 34 females and 11 males were enrolled.  
Average age of the patients was 32.2 years (19-56 years). We found no 
differences in the VEMP score or syncope prevalence between genders (p>0.05). 
In the CIS group there were 15 (33.3%) cases of optic neuritis, 11 (24.5%) of 
incomplete transverse myelitis, 15 (33.3%) brainstem/cerebellar, 3 (6.7%) cases 
of hemispheral and 1 (2.2%) multifocal type of CIS. Median EDSS was 1.0 (0-3.0). 
Median cVEMP score was 1 (0-6), median oVEMP score was 3 (0-6), and median 
VEMP score was 4 (0-12). 
Brain MRI was performed in all patients showing demyelinating lesions 
consistent with MS. In 42 patients brain MRI and in 33 patients cervical spinal 
cord MRI was available for detailed analysis (3 patients had a radiologist report 
without images available for further analysis). 
The number of patients with autonomic dysfunction is presented in Table 1. 
 
 
3.2. Primary outcomes  
 
There was no difference in the VEMP score between patients with and without 
signs of sympathetic or parasympathetic dysfunction evident on the CASS. 
However, patients with syncope had a significantly lower VEMP score compared 
to patients without syncope (p<0.01). Patients with OH showed a trend of higher 
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VEMP scores compared to patients without syncope, albeit with borderline 
statistical significance (p=0.06). All results are presented in Table 2. 
Since patients with a higher VEMP score had a lower chance to develop syncope, 
we further wanted to determine the cut-off VEMP score value that best 
differentiates between MS patients with and without syncope. We found that a 
VEMP score has an area under the ROC curve of 0.804 (Figure 3) and that a 
VEMP score value of 5 has a sensitivity of 87.5% with a specificity of 40.5%. 
When looking at oVEMP and cVEMP scores separately, oVEMP has an area under 
the ROC curve of 0.755 and an oVEMP score value of 3 has a sensitivity of 87.5%, 
with a specificity of 54.0% (Figure 3); while a cVEMP score which has an area 
under the ROC curve of 0.721 and a cVEMP score value of 1 has a sensitivity of 
87.5%, and a specificity of 57.0% (Figure 3). 
 
 
3.3. Secondary outcomes 
Results of the MRI analysis are presented in Table 3. There was no difference in 
the presence of lesions in the midbrain, pons, medulla oblongata or cervical 
spinal cord between patients with or without any of the studied autonomic 
parameters.  
We subsequently tested which combination of the VEMP score and MRI results 
had the best sensitivity and specificity indicating that the MS patient can develop 
syncope. We found that the model consisting of a VEMP score of ≤5 and normal 
MRI of the midbrain and cervical spinal cord has a sensitivity of 83% and 
specificity of 83% for the possibility that a patient with MS will develop syncope. 
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4. Discussion 
 
The principal finding of this study is that MS patients without brainstem 
involvement have a greater chance to develop syncope. Because we used evoked 
potentials that evaluate function of the brainstem, this finding leads to the 
deduction that functional integrity of the brainstem is needed in order to 
develop syncope. Although this may seem contradictory, several hypotheses and 
lines of evidence can explain this association.  
It has been suggested that vasovagal syncope is a reaction that humans have 
acquired as a self-preservation response. (16) Most common triggers for 
syncope are emotions, followed by different situations (e.g. standing) or physical 
experience (e.g. warmth). (17) As one of the most common triggers for syncope 
is fear of blood and/or sharp objects, the “paleolithic threat hypothesis” has been 
proposed as an explanation. (18) Authors of this hypothesis suggest that the 
vasovagal syncope in these situations represents an atavism of a survival 
advantage from the evolutionary period for women and children/adolescents 
(who were non-combatants at that time), who are even nowadays prone to 
develop syncope. Its very frequent occurrence and genetic propensity suggest 
that syncope is not selected against over time, so it can be speculated that 
persistence of this condition has some usefulness. (19,20) In line with this, 
several advantages of vasovagal syncope have been suggested. One view is that 
syncope could be considered a transitory means of escape from a momentarily 
intolerable world. (16) The brain self-preservation theory, on the other hand, 
argues that loss of postural tonus may be beneficial for brain perfusion. 
According to this theory, the brain has become so important for humans that it 
 16 
could be speculated that it has been necessary for it to acquire its own self-
preservation autonomy. (16) It is speculated that the initiation of the syncope 
starts in the brainstem, when midbrain nuclei become aware of the circulatory 
changes precluding maintenance of sufficient blood supply to the brain leading 
to a sudden reversal in their operational activity towards a reaction in which 
salvaging the brain’s blood supply becomes the main goal. (16) Therefore, 
brainstem functionality is crucial for syncope development. Furthermore, the 
afferent pathways in the vasovagal syncope reflex arch, which are conducted by 
unmyelinated vagal afferents to the brainstem, have recently been reconsidered. 
Firstly, there is good evidence to suggest that syncope can occur in patients after 
cardiac transplantation, when the heart has undergone major efferent and 
afferent denervation; and second, syncope may occur with the central stimulus 
in the supine position when the heart is not empty. (21,22,23) 
Furthermore, two neurophysiological observations support the brain self-
preservation theory: important changes in cerebral hemodynamics occur much 
earlier than the vasovagal reactions and electroencephalographic slowing which 
closely follows reduction of systemic pressure corresponds to the onset of 
transient loss of consciousness. (24,25) Our finding that a VEMP score ≤5 and 
normal MRI of the midbrain and cervical spinal cord has sensitivity of 83% and 
specificity of 83% indicating the possibility that the patient with MS can develop 
syncope, is in line with the previously mentioned hypotheses and indicates that 
normal function of the brainstem is needed for the development of syncope. One 
can hypothesize that, according to the brain self-preservation theory, 
interruption of brainstem pathways responsible for the initiation of syncope by 
MS lesions prevents the development of the vasovagal syncope. Our findings 
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indicate that evaluation of the brainstem with neurophysiological methods, 
which measure the function of these pathways, is more important than 
morphological detection of the lesions with conventional MRI. 
The opposite was seen for the structural disorders of the autonomic nervous 
system, namely OH. CIS patients exhibiting OH during PP-HUTT showed a higher 
VEMP score compared to patients without OH, although this did not reach 
statistical significance (p=0.06). This is in line with previous studies, which 
showed increased frequency of autonomic dysfunction in patients who have 
lesions in the pons. (5) On the other hand conventional MRI alone did not 
correlate with any type of autonomic dysfunction, again emphasizing the 
inability of MRI to depict the whole spectrum of protean MS manifestations. 
However, newer MRI techniques like magnetization transfer ratio or three-
dimensional MRI estimation of volume loss may prove valuable in future studies. 
(26,27) 
This study has several limitations. The first one is that MRIs were not available 
for detailed analysis in all patients, as mentioned in the methods section. The 
second one is that patients with very early MS were enrolled and it is known that 
prevalence of autonomic dysfunction increases with disease duration. (28) It can 
be presumed that more cases of OH would be present if patients with more 
advanced disease were included, enabling better estimation of suspected 
association between brainstem and autonomic dysfunction. On the other hand 
one can speculate that the relatively high prevalence of syncope (17.8%) in CIS 
patients compared with previously published studies of prevalence of syncope in 
the healthy population (around 3%) could indicate possible association between 
these two conditions. (29) However, more recent studies have shown much 
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higher prevalence of syncope (17-34%) in young adults (the population at risk of 
developing MS), and we have recently shown no association between syncope 
and MS (17,30). 
In conclusion, based on the results of previous studies and current results, it 
seems that pathophysiological mechanisms underlying functional and structural 
disorders of autonomic nervous system in MS differ significantly. While 
preserved brainstem function is needed for development of syncope, structural 
disorders like OH could be associated with brainstem dysfunction. Further 
studies delineating these differences are warranted. 
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Tables  
 
Table 1. The prevalence of different types of autonomic dysfunction in the CIS 
cohort. 
Autonomic dysfunction Positive N (%) Negative N(%) 
Adrenergic index ≥1* 19 (43.2%) 25 (56.8%) 
Cardiovagal index ≥1 3 (6.7%) 42 (93.3%) 
OH 4 (8.9%) 41 (91.1%) 
Syncope 8 (17.8%) 37 (82.2%) 
POTS 5 (11.1%) 40 (88.9%) 
OH Orthostatic hypotension; POTS Postural orthostatic tachycardia syndrome 
* One patient was not able to perform Valsalva maneuver, so the adrenergic 
index could not be calculated. 
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Table 2. Differences in the VEMP score between different forms of autonomic 
dysfunction. 
Autonomic 
dysfunction 
oVEMP 
(ranks / 
median) 
p 
value 
cVEMP 
(ranks / 
median) 
p 
value 
VEMP 
(ranks / 
median) 
p 
value 
Adrenergic 
index ≥1* 
N 21.00/2.5 0.36 22.06/1 0.78 21.06/4 0.39 
P 24.47/3 23.08/2 24.39/5 
Cardiovagal 
index ≥1 
N 23.65/3 0.22 22.93/1 0.92 23.61/5 0.26 
P 13.83/0 24.00/2 14.50/3 
OH N 21.91/3 0.08 22.16/1 0.18 21.85/4 0.06 
P 34.13/5 31.63/3.5 34.75/7.5 
Syncope N 25.04/4 0.02 24.77/2 0.05 25.43/5 <0.01 
P 13.56/1 14.81/0 11.75/1 
POTS N 23.95/4 0.18 23.44/1.5 0.53 23.73/4.5 0.31 
P 15.40/1 19.50/0 17.20/3 
OH Orthostatic hypotension; POTS Postural orthostatic tachycardia syndrome; N 
Negative; P Positive 
* One patient was not able to perform Valsalva maneuver, so the adrenergic 
index could not be calculated. 
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Table 3. Correlation between different forms of autonomic dysfunction and 
presence of demyelinating lesions in different parts of the brainstem. 
Autonomic 
dysfunction 
Midbrain p Pons p Medulla p C spine p 
N P N P N P N P 
Adrenergic 
index* 
0 22 1 0.22 17 6 0.59 20 3 0.73 10 8 0.69 
1 11 3 9 5 11 3 5 5 
3 3 1 2 2 3 1 3 1 
Cardiovagal 
index 
0 34 5 1.00 25 14 0.54 32 7 1.00 18 14 1.00 
1 3 0 3 0 3 0 1 0 
OH N 34 4 0.41 26 12 0.59 32 6 0.53 16 13 0.62 
P 3 1 2 2 3 1 3 1 
Syncope N 30 4 1.00 24 10 0.41 30 4 0.11 14 13 0.21 
P 7 1 4 4 5 3 5 1 
POTS N 33 4 0.49 24 13 0.65 31 6 1.00 17 12 1.00 
P 4 1 4 1 4 1 2 2 
OH Orthostatic hypotension; POTS Postural orthostatic tachycardia syndrome; N 
Negative; P Positive 
* One patient was not able to perform Valsalva maneuver, so the adrenergic 
index could not be calculated. 
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Figures 
 
Figure 1. Tracings from oVEMP and cVEMP responses form a CIS patient with 
syncope. Two traces in the lower row (SCMR and SCML) present cVEMP, and the 
traces in the upper row (OL and OR) presents oVEMP. The VEMP score is 0. 
Timescale is in ms, from -20 ms before the appearance of the stimulus and 100 
ms after the appearance of stimulus. 0 ms on the x-axis presents moment in 
which the stimulus is presented to the participant.  Sensitivity is presented in µV 
(microvolt). cVEMP traces and oVEMP traces have different sensitivity. 
SCMR – right sternocleidomastoid response, SCML – left sternocleidomastoid 
response, OL – left ocular response, OR – right ocular response. 
 
 
Figure 2. Tracings from oVEMP and cVEMP responses form a CIS patient without 
syncope. Two traces in the lower row (SCMR and SCML) present cVEMP, and the 
traces in the upper row (OL and OR) presents oVEMP. The VEMP score is 5 
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(normal response of both oVEMP responses (OL and OR)=0, conduction block of 
SCMR=3, reduced amplitude of SCML=2, equals the VEMP score of 5). Timescale 
is in ms, from -20 ms before the appearance of the stimulus and 100 ms after the 
appearance of stimulus. 0 ms on the x-axis presents moment in which the 
stimulus is presented to the participant.  Sensitivity is presented in µV 
(microvolt). cVEMP traces and oVEMP traces have different sensitivity. 
SCMR – right sternocleidomastoid response, SCML – left sternocleidomastoid 
response, OL – left ocular response, OR – right ocular response. 
 
Figure 3. ROC curves for oVEMP (left), cVEMP (middle) and VEMP (right) scores. 
 
